Serotonin selective antidepressant drugs: past, present, future

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Classic antidepressants like MAOIs and imipramine-type drugs modulate serotonin (5-HT) neuron function.
• This modulation has significantly impacted the study and treatment of depressive illness.
• Antidepressant drugs serve as crucial research tools for understanding depression's pathophysiology.

Purpose of the Study:

• To develop antidepressant drugs with more selective effects on key nerve cells implicated in depression.
• To minimize side effects and potentially enhance therapeutic outcomes.
• To explore the broad-spectrum actions of serotonergic drugs beyond depression.

Main Methods:

• Development of selective serotonin (5-HT) reuptake inhibitors (SSRIs) like fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram.
• Clinical evaluation of SSRIs against standard antidepressants.
• Investigation into the effects of selective 5-HT receptor agonists, such as gepirone.

Main Results:

• Selective 5-HT uptake inhibitors demonstrate antidepressant effects comparable to established treatments.
• These newer drugs present a different side effect profile.
• Serotonergic drugs exhibit a wide range of effects, including in obsessive-compulsive disorder and panic disorder.

Conclusions:

• Selective 5-HT drugs offer equivalent antidepressant efficacy with distinct side effect profiles.
• Their efficacy extends to conditions like obsessive-compulsive disorder and panic disorder.
• Further research with selective 5-HT receptor modulators is needed to fully understand the neurobiological underpinnings of mood and anxiety disorders.